A 71-year-old woman with hypertension and type 2 diabetes is found to have persistent nonvalvular atrial fibrillation. Her heart rate is controlled on metoprolol. Her eGFR is 70 mL/min, and she has no history of bleeding. Which stroke-prevention strategy is most appropriate?
Show answer & explanation
Answer: A
Apixaban: Correct. Her CHA2DS2-VASc score is 4 (age 65–74, female sex, hypertension, diabetes), so oral anticoagulation is indicated. Current guidelines prefer a DOAC such as apixaban over warfarin for nonvalvular AF.
Aspirin 81 mg daily: Aspirin alone is not recommended for stroke prevention in AF. It gives little protection and still carries bleeding risk.
No antithrombotic therapy: No therapy would be reasonable only at a CHA2DS2-VASc of 0 in men or 1 in women. Her score of 4 puts her at substantial stroke risk.
Aspirin plus clopidogrel: Dual antiplatelet therapy is inferior to oral anticoagulation for AF stroke prevention, with similar bleeding risk.
Calculate CHA2DS2-VASc. Anticoagulate at ≥2 in men or ≥3 in women, and prefer a DOAC over warfarin in nonvalvular AF. Aspirin alone is not adequate.